NMP-2008-4.0-1 Development of nanotechnology-based systems for diagnosis and/or therapy for diabetes, musculo-skeletal or inflammatory diseases (in coordination with Theme HEALTH)
Technical content/scope: Within the objective of reinforcing the competitiveness of European industry addressing healthcare, proposals are called for with the aim of developing nanotechnology-based systems for diagnosis and/or therapy for diabetes, muscolo-skeletal or inflammatory diseases. Where meaningful, research should address the combination of diagnosis and therapy (theranostics) in multi purpose systems. They should demonstrate high specificity, efficacy and where appropriate biocompatibility. Linked animal testing should be kept to the minimum needed and should be replaced by in vitro testing wherever possible. This call addresses only human healthcare.
Funding scheme: Large-scale integrating collaborative projects.
Specific features: In order to ensure industrial relevance and impact of the research effort, the active participation of industrial partners represents an added value to the activities and this will be reflected in the evaluation. Activities other than research could be included as appropriate, such as specific education modules, pre- and co-normative activities, or the analysis of existing and required regulations. Gender issues should be considered, where appropriate.
Expected impact: (i) Better and more reliable diagnostics and/or therapy against present methods; (ii) delivery of improved health care to citizens and -where the case- also to livestock; (iii) increased competitiveness of European industry in this high value added and fast growing field.